APA (7th ed.) Citation

Hao, H., Li, Z., Qiao, S., Qi, Y., Xu, X., Si, J., . . . Kang, L. (2023). Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora. Atherosclerosis (00219150), 371, 32. https://doi.org/10.1016/j.atherosclerosis.2023.03.011

Chicago Style (17th ed.) Citation

Hao, Han, et al. "Empagliflozin Ameliorates Atherosclerosis via Regulating the Intestinal Flora." Atherosclerosis (00219150) 371 (2023): 32. https://doi.org/10.1016/j.atherosclerosis.2023.03.011.

MLA (9th ed.) Citation

Hao, Han, et al. "Empagliflozin Ameliorates Atherosclerosis via Regulating the Intestinal Flora." Atherosclerosis (00219150), vol. 371, 2023, p. 32, https://doi.org/10.1016/j.atherosclerosis.2023.03.011.